Fidelity Advisor Health Care I (FHCIX)

Fund Assets	3.34B
Expense Ratio	0.71%
Min. Investment	$0.00
Turnover	74.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 26, 2025

Previous Close	76.50
YTD Return	15.37%
1-Year Return	24.69%
5-Year Return	18.53%
52-Week Low	58.37
52-Week High	78.42
Beta (5Y)	0.74
Holdings	155
Inception Date	Sep 3, 1996

About FHCIX

The Fidelity Advisor Health Care Fund is a mutual fund focused on capital appreciation. It primarily invests in common stocks of companies engaged in healthcare products and services, allocating at least 80% of its assets to these sectors. The fund targets companies involved in the design, manufacture, or sale of healthcare-related products or services. Notable holdings span across major healthcare sectors, including pharmaceuticals, medical devices, and health insurance providers. Managed by experienced professionals, the fund benefits from deep analytical resources and a thoughtful investment approach, making it a significant player in the healthcare investment landscape. Its large growth investment style and substantial assets under management underscore its market significance within the healthcare sector.

• Fund Family: Fidelity
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: FHCIX
• Share Class: Class I
• Index: S&P 500 TR

Performance

FHCIX had a total return of 24.69% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.10%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FIKCX	Class Z	0.59%
FACDX	Class A	0.96%
FACTX	Class M	1.21%
FHCCX	Class C	1.71%

Top 10 Holdings

40.48% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	7.66%
Danaher Corporation	DHR	6.75%
Thermo Fisher Scientific Inc.	TMO	6.31%
UnitedHealth Group Incorporated	UNH	4.17%
Johnson & Johnson	JNJ	3.78%
AbbVie Inc.	ABBV	3.62%
argenx SE	ARGX	2.09%
Merck & Co., Inc.	MRK	2.09%
West Pharmaceutical Services, Inc.	WST	2.06%
Ascendis Pharma A/S	ASND	1.95%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2025	$7.462	Dec 29, 2025
Dec 26, 2024	$6.856	Dec 27, 2024
Dec 17, 2021	$4.152	Dec 20, 2021
Dec 18, 2020	$3.992	Dec 21, 2020
Dec 20, 2019	$0.289	Dec 23, 2019
Dec 7, 2018	$2.218	Dec 10, 2018

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 7, 2026

Data Sources Report a data error